Dear Reader,
When a new chip can run at the speed of light, the game changes.
This is the reality of “TF3” — a man-made crystal that could replace silicon entirely.
Right now, one American company is producing it commercially.
Their clients already include NASA and top-tier medical research institutions.
But this is still under the radar — and that’s the opportunity.
When Wall Street wakes up, you’ll wish you’d acted sooner.
Good investing,
Rachel Gearhart
Publisher, The Oxford Club
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Written by Gabriel Osorio-Mazilli. Published 10/4/2025.
Key Points
- Lower interest rates and infrastructure spending could spark a rebound in the U.S. industrial sector, creating opportunities for Chemours, Dow, and Nucor.
- Chemours benefits from auto and housing tailwinds, Dow stands to gain from restocking cycles and federal infrastructure projects, and Nucor is well-positioned for rising steel demand.
- Despite recent volatility, analysts see double-digit upside potential across these three industrial stocks, supported by both price action and fundamentals.
Price action is a key metric when evaluating whether an investment setup is bullish or bearish. But focusing solely on price trends without tying them to underlying fundamentals risks investing blindly.
The U.S. industrial sector is under pressure from shifting consumer and business spending, changing inflation expectations, and new trade tariffs on various materials. Yet uncertainty can also create opportunity for investors who position themselves correctly.
Goldman Sachs Says Gold Will Hit $4,900 (Here's How to Profit Monthly) (Ad)
If you've been watching gold's historic run and wondering if it's too late… I've got good news.
Because there's a $15 fund tied directly to gold's surge that's still paying massive income…
Up to 64% annually — with payouts every 30 days.
Three names worth considering are Chemours Co. (NYSE: CC), Dow Inc. (NYSE: DOW), and Nucor Corp. (NYSE: NUE). All three exhibit supportive price action, but it's time to connect that momentum back to fundamentals.
Chemours Stock: Direct Consumer Exposure
Chemours may not appear to be a consumer stock at first glance, but its specialty chemicals are used extensively in automotive and residential paints and coatings. Those end markets stand to gain from the Federal Reserve's recent interest rate cuts.
Lower financing costs make cars more affordable, boosting demand and production—each new vehicle requiring paint and coating. The housing market tells a similar story: mortgage applications and building permits are near cyclical lows but should rebound as rates fall, driving further demand for Chemours' products.
Analysts are taking notice. In September 2025, Truist Financial's Peter Osterland set a $21 per-share price target, well above the consensus of $17.63 and implying roughly 36% upside—even after a 25% rally last quarter.
A Restocking Cycle Set for Dow Stock
Lower interest rates are also reviving business activity. After years of tight monetary policy and strategic slowdown to curb inflation, the shift to looser rates could spark a restocking cycle for inventories of consumer goods, perishables, and staples.
Dow is well positioned to benefit, supplying polyurethanes and coatings used in packaging and materials for industrial construction. This tailwind may strengthen further under President Trump's "One Big Beautiful Bill", which directs billions into infrastructure projects.
Although the stock trades at just 41% of its 52-week high—suggesting it remains in a deep bear market—Wall Street consensus remains bullish. The current price target of $30 per share sits about 30% above today's levels, offering investors the potential to capitalize on the gap with solid fundamental support.
Multiple Tailwinds for Nucor's Next Rally
Infrastructure spending isn't just about chemicals and coatings; it also drives steel demand. As the largest U.S. steelmaker, Nucor stands to gain from both residential and industrial construction rebounds.
Falling interest rates not only boost demand but also lower Nucor's expansion costs. In this capital-intensive industry, reduced financing expenses can meaningfully improve margins and pricing power.
Nucor should see costs decline even as prices rise on stronger demand, creating a favorable outlook for earnings per share. Investors have already seen signs of this strength: Nucor reported $2.60 in EPS last quarter, topping the MarketBeat consensus of $2.54. With the stock up 16% year-to-date, its upside could expand further once Fed rate cuts ripple through the economy ahead of 2025's end.
This email communication is a paid sponsorship from The Oxford Club, a third-party advertiser of MarketBeat. Why did I receive this email content?.
This ad is sent on behalf of The Oxford Club, 105 W. Monument Street Baltimore, MD 21201. If you would like to opt out from receiving offers from The Oxford Club, please click here
If you have questions about your subscription, feel free to contact our South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. U.S.A..
